Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer's Bond Sales Ranks Among Largest Ever
04:55pm, Wednesday, 17'th May 2023
Pfizer's $31 billion bond sale ranks among the largest ever, but it's still only half the size, adjusted for inflation, of Verizon's mammoth 2013 deal.
Pfizer to raise $31 billion in debt offering to fund Seagen acquisition, SEC filing shows
12:32pm, Wednesday, 17'th May 2023
The debt offering by Pfizer to buy cancer drug maker Seagen comes as Apple, Merck and T-Mobile tap the U.S. bond market ahead of the debt ceiling standoff.
Pfizer (PFE) to Raise $31B in Debt to Fund Seagen (SGEN) Deal
11:17am, Wednesday, 17'th May 2023
Pfizer (PFE) offers bonds worth $31 billion to fund its pending acquisition of cancer drugmaker, Seagen (SGEN).
Pfizer Prices $31 Billion Debt Offering to Fund Seagen Acquisition
06:47am, Wednesday, 17'th May 2023
Pfizer's acquisition of cancer-focused biotech Seagen, announced in March, would be its biggest since 2009. The deal faces risks.
Is This Dow Jones Stock a Buy for Income Investors?
05:06am, Wednesday, 17'th May 2023
Amgen's revenue and profits dipped in the first quarter. The company's market-beating dividend is poised to rise moving forward.
Pfizer Sells $31 Billion of Bonds in Fourth-Largest Deal Ever
07:46pm, Tuesday, 16'th May 2023
Pfizer Inc. sold $31 billion of debt, according to a person with knowledge of the matter. The fourth-largest US bond sale ever will help the pharmaceutical giant finance its purchase of Seagen Inc.
Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say
12:35pm, Tuesday, 16'th May 2023
The FDA is slated to make a decision on whether to approve Pfizer's shot in August, just before respiratory syncytial virus season in the fall.
Pfizer CEO says Medicare will likely face legal action over drug price negotiations
05:23pm, Thursday, 11'th May 2023
Pfizer CEO Albert Bourla argued the Biden administration's plan will cut profits and force Big Pharma companies to pull back on developing medicines.
The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer
10:23am, Thursday, 11'th May 2023
The global RSV vaccine market isn't all that big, and healthcare giants are battling for market share. Potential vaccines from Pfizer and Moderna have demonstrated high efficacy in late-stage trials.
As COVID public health emergency ends, ‘whack-a-mole' virus won't be easy to track
02:30pm, Wednesday, 10'th May 2023
As the U.S. COVID-19 public health emergency comes to an end on Thursday, the fight against COVID goes on–-and some new challenges begin for those who hope to keep the virus at bay.
U.S. Wide-Moat Stocks On Sale - The May 2023 Heat Map
12:39am, Wednesday, 10'th May 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
10:40am, Monday, 08'th May 2023
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
2 Top Healthcare Stocks to Buy Right Now
08:45am, Monday, 08'th May 2023
Pfizer's COVID vaccine may be fading, but the rest of its product portfolio and pipeline is quite strong. Elevance Health should significantly benefit from strong growth in the health insurance indust
5 Conservative And Cheap Dividend Stocks To Invest In - May 2023
09:00am, Saturday, 06'th May 2023
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying and are offering large discounts to their historical norms. We go over
Uber and Pfizer Update Their Investors About How Things Are Going
06:26pm, Friday, 05'th May 2023
We also chat about whether there is a "new normal" for start-ups and venture capital.
